Filtered By:
Infectious Disease: Coronavirus
Drug: Docetaxel
This page shows you your search results in order of date.
Order by Relevance | Date
Total 4 results found since Jan 2013.
COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report
Mol Clin Oncol. 2021 Jun;14(6):117. doi: 10.3892/mco.2021.2279. Epub 2021 Apr 8.ABSTRACTPatients receiving chemotherapy are at high risk for severe infections and complications such as acute respiratory syndrome. The most commonly used adjuvant chemotherapy protocols (docetaxel-cyclophosphamide every 3 weeks or the dose-dense regimen, doxorubicin-cyclophosphamide every 2 weeks followed by paclitaxel) incorporate granulocyte-colony stimulating factor (G-CSF). G-CSF is routinely administered to prevent chemotherapy-associated neutropenia but often results in significant neutrophilia. The present case describes a patient with...
Source: Clinical Genitourinary Cancer - April 27, 2021 Category: Cancer & Oncology Authors: Rinat Yerushalmi Moshe Sagi Hadar Goldvaser Jonathan Daliot Raz Mutai Ilan Krause Source Type: research
